Allay Therapeutics Appoints New Chief Medical Officer
David Hewitt, M.D. Appointed as New Allay Therapeutics Chief Medical Officer Clinical-stage biotechnology company Allay Therapeutics recently announced…
Presenters Announced for 2021 William Blair Biotech Conference
A wide range of biotechnology companies have announced presentations at the upcoming William Blair Biotech Conference slated to…
Cel-Sci Announces Multikine Immunotherapy Significantly Improves Overall Survival Benefit for Cancer Head & Neck Patients in Phase 3 Trial
Data Shows Significant Overall Survival Benefit for Cancer Patients with Multikine Treatment Regimen Followed by Surgery & Radiotherapy…
Moderna Announces Ministry of Food and Drug Safety of South Korea (MFDS) COVID-19 Authorization
Moderna, Inc., (NASDAQ: MRNA) has recently been authorized by the Ministry of Food and Drug Safety of South…
COVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive – Virology Experts Weigh In
Professional Major League Baseball organization the New York Yankees have been rocked this week with COVID-19 after 8…
Capricor CEO to Present at American Society of Gene and Cell Therapy Annual Meeting Ahead of Q1 Earnings Update
May 13 is a busy day for biotechnology company Capricor Therapeutics (NASDAQ: CAPR). The company which focuses on…
NTx Hires Bristol-Myers Squibb Veteran Biopharma Executive Nancy Rurkowski to Join its Board of Directors
The 35-year veteran of Bristol-Myers Squibb brings manufacturing operations and product launch leadership expertise to drive NTx commercialization…
Aerobiotix Announces Raise of $25M Growth Equity Financing Led by Healthcare Investment Firm Vivo Capital
Aerobiotix, a pioneer in airborne infection control products that provide real-time, in room solutions for hospitals, ASCs, long…
Maxwell Biosciences, Makers of CLAROMER, Hire John Lord, Ph.D., as VP of Research and Development
Austin, Texas based biotechnology company Maxwell Biosciences have announced the hiring of Dr. John Lord as Vice President…
Ex-Lilly CEO Josh Bilenker & Ex-Novartis Head of Oncology Jeff Engelman Announce Treeline Biosciences
Two powerhouse executives have joined forces to form a brand new cancer Biotech company. Josh Bilenker, M.D., and…
Repertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery & T Cell Receptors
The collaboration between Repertoire and Yale seeks to identify novel antigenic reactivity of T cells in patients with…
Welcome To BioTech Health X
The New Leader in BioTech News, BioTech Stock Information & BioTech Industry Analysis BioTech Health X delivers the…